• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

AC2-26 Inhibitor – TFA

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5763583

Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-kappaB and MAPK pathways in the injured lung tissue. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Ac2-26 TFA, Inhibitor
Full Product Name
Ac2-26 TFA
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
3203.45
Solubility
H2O: Soluble
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C143H211F3N32O46S

Product References and Citations for Ac2-26, inhibitor

Liao WI, et al. Ac2-26, an Annexin A1 Peptide, Attenuates Ischemia-Reperfusion-Induced Acute Lung Injury. Int J Mol Sci. 2017 Aug 15;18(8). pii: E1771.

Other Notes

Small volumes of Ac2-26, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Ac2-26 purchase

MBS5763583 is an inhibitor targeting Ac2-26. Also known as Ac2-26 TFA.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000